As of Oct 18
| +0.30 / +0.79%|
The 22 analysts offering 12-month price forecasts for Boston Scientific Corp have a median target of 48.00, with a high estimate of 53.00 and a low estimate of 45.00. The median estimate represents a +24.77% increase from the last price of 38.47.
The current consensus among 23 polled investment analysts is to Buy stock in Boston Scientific Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.